2021 德国指南：皮肤手术中抗凝剂和抗血小板药物的管理

2021-10-19 国外皮肤性病相关专家小组（统称） J Dtsch Dermatol Ges

在外科患者的围手术期管理中，口服抗凝剂（OAC）和血小板聚集抑制剂（PAI）仍然是一个挑战。

中文标题：

英文标题：

S3 guideline: Management of anticoagulants and antiplatelet agents in cutaneous surgery

发布机构：

国外皮肤性病相关专家小组（统称）

发布日期：

2021-10-19

简要介绍：

在外科患者的围手术期管理中，口服抗凝剂（OAC）和血小板聚集抑制剂（PAI）仍然是一个挑战。在皮肤科手术中，抗血栓药物的围手术期管理也存在很大差异，本文主要针对皮肤手术中抗凝剂和抗血小板药物的管理提供指导建议。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=307b01c00221513a, title=2021 德国指南：皮肤手术中抗凝剂和抗血小板药物的管理, enTitle=S3 guideline: Management of anticoagulants and antiplatelet agents in cutaneous surgery, guiderFrom=J Dtsch Dermatol Ges, authorId=0, author=, summary=在外科患者的围手术期管理中，口服抗凝剂（OAC）和血小板聚集抑制剂（PAI）仍然是一个挑战。, cover=https://img.medsci.cn/20211019/1634653179735_5579292.jpg, journalId=0, articlesId=null, associationId=1324, associationName=国外皮肤性病相关专家小组（统称）, associationIntro=, copyright=0, guiderPublishedTime=Tue Oct 19 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">在外科患者的围手术期管理中，口服抗凝剂（OAC）和血小板聚集抑制剂（PAI）仍然是一个挑战。在皮肤科手术中，抗血栓药物的围手术期管理也存在很大差异，本文主要针对皮肤手术中抗凝剂和抗血小板药物的管理提供指导建议。</span></p>, tagList=[TagDto(tagId=116212, tagName=皮肤手术)], categoryList=[CategoryDto(categoryId=39, categoryName=皮肤与性病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=1124, guiderKeyword=抗血小板药物, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3765, appHits=39, showAppHits=0, pcHits=1423, showPcHits=3726, likes=0, shares=7, comments=5, approvalStatus=1, publishedTime=Tue Oct 19 22:29:05 CST 2021, publishedTimeString=2021-10-19, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Tue Oct 19 22:23:04 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Sat Jan 06 17:43:35 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 德国指南：皮肤手术中抗凝剂和抗血小板药物的管理.pdf)])

2021 德国指南：皮肤手术中抗凝剂和抗血小板药物的管理.pdf

下载请点击：

评论区 (4)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1193155, encodeId=e4701193155ef, content=好<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61da5236552, createdName=147b04a1m26暂无昵称, createdTime=Sun Feb 13 23:24:11 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066238, encodeId=bb941066238f0, content=very good idea, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47445626421, createdName=ms6000001387765207, createdTime=Tue Nov 02 14:54:59 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062221, encodeId=79411062221d0, content=想多了很多，谢谢老师的指导, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5b3006368, createdName=1436749007, createdTime=Wed Oct 20 10:55:21 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062151, encodeId=40811062151cd, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Oct 20 07:04:38 CST 2021, time=2021-10-20, status=1, ipAttribution=)]
2022-02-13 147b04a1m26暂无昵称

好#学习#

79 0
[GetPortalCommentsPageByObjectIdResponse(id=1193155, encodeId=e4701193155ef, content=好<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61da5236552, createdName=147b04a1m26暂无昵称, createdTime=Sun Feb 13 23:24:11 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066238, encodeId=bb941066238f0, content=very good idea, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47445626421, createdName=ms6000001387765207, createdTime=Tue Nov 02 14:54:59 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062221, encodeId=79411062221d0, content=想多了很多，谢谢老师的指导, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5b3006368, createdName=1436749007, createdTime=Wed Oct 20 10:55:21 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062151, encodeId=40811062151cd, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Oct 20 07:04:38 CST 2021, time=2021-10-20, status=1, ipAttribution=)]
2021-11-02 ms6000001387765207

very good idea

106 0
[GetPortalCommentsPageByObjectIdResponse(id=1193155, encodeId=e4701193155ef, content=好<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61da5236552, createdName=147b04a1m26暂无昵称, createdTime=Sun Feb 13 23:24:11 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066238, encodeId=bb941066238f0, content=very good idea, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47445626421, createdName=ms6000001387765207, createdTime=Tue Nov 02 14:54:59 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062221, encodeId=79411062221d0, content=想多了很多，谢谢老师的指导, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5b3006368, createdName=1436749007, createdTime=Wed Oct 20 10:55:21 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062151, encodeId=40811062151cd, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Oct 20 07:04:38 CST 2021, time=2021-10-20, status=1, ipAttribution=)]
2021-10-20 1436749007

想多了很多，谢谢老师的指导

116 0
[GetPortalCommentsPageByObjectIdResponse(id=1193155, encodeId=e4701193155ef, content=好<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61da5236552, createdName=147b04a1m26暂无昵称, createdTime=Sun Feb 13 23:24:11 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066238, encodeId=bb941066238f0, content=very good idea, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47445626421, createdName=ms6000001387765207, createdTime=Tue Nov 02 14:54:59 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062221, encodeId=79411062221d0, content=想多了很多，谢谢老师的指导, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5b3006368, createdName=1436749007, createdTime=Wed Oct 20 10:55:21 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062151, encodeId=40811062151cd, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Oct 20 07:04:38 CST 2021, time=2021-10-20, status=1, ipAttribution=)]
2021-10-20 微探

学习学习

128 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

皮肤与性病指南

2021 德国指南：皮肤手术中抗凝剂和抗血小板药物的管理

拓展阅读

科室

工具

服务